Patients at high risk for chronic kidney disease (CKD) should be offered screening

  • Diabetes
  • Hypertension
  • Patients with vascular disease (Ischaemic heart disease, cerebrovascular disease, peripheral vascular disease, cardiac failure)
  • High risk of obstructive uropathy (neurogenic bladder, urine stone disease)
  • Use of potentially nephrotoxic drugs (ACEI/ARBs/NSAIDs/Lithium/ciclosporin)
  • Multisystem disease that potentially involves the kidney
  • A first degree relative with stage 5 CKD

Part 1 Newly Detected Abnormal eGFR

Part 2 Newly Detected Abnormal eGFR


Abbreviation Meaning
eGFR Estimated glomerular filtration rate
ACEI Angiotensin-converting-enzyme inhibitors
ARBs Angiotensin receptor blockers
NSAIDs Nonsteroidal anti-inflammatory drugs

Last reviewed: 30/11/2020

Next review date: 30/11/2023

Author(s): Renal MDT.

Version: 2

Approved By: TAM subgroup of ADTC

Reviewer name(s): Consultant Nephrologist.

Document Id: TAM362